The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer (CEO), effective Monday, July 14, 2025.
Prof. Opuni succeeds Dr. Delese Mimi Darko, who has led the FDA since 2017 but recently accepted a notable position as the Director General of the Africa Medicines Agency (AMA), marking a significant milestone in her impressive career in public health leadership.
Before stepping into his new role, Prof. Opuni served as the Board Chairman of the FDA, where he gained extensive experience in public health policy, regulatory oversight, and institutional governance. His background equips him well to tackle the challenges ahead.
In a statement regarding the appointment, the FDA extended its warmest congratulations to Prof. Opuni, expressing confidence in his ability to lead the Authority in fulfilling its essential mandate of safeguarding public health and safety in Ghana.
Prof. Opuni assumes leadership at a critical time for the FDA, as the Authority is focused on strengthening regulatory systems, enhancing consumer protection, and ensuring the safety and efficacy of food, drugs, and other regulated products across the nation.
His expertise and vision are expected to play a pivotal role in advancing these goals and addressing the ever-evolving landscape of public health in Ghana.
Source: Apexnewsgh.com
